EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis

Zihan Deng, Binghui Li, Muyang Yang, Lisen Lu, Xiujuan Shi, Jonathan F Lovell, Xiantao Zeng, Weidong Hu, Honglin Jin

Journal of Nanobiotechnology · 05.05.2024 · 22 (1)

DOI: 10.1186/s12951-024-02496-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nanobiotechnology, online erschienen am 05.05.2024. Verfasst von Zihan Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, ZhongNan Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Ferroptosis, Prostatic Neoplasms, Tumor Microenvironment, Cell-Derived Microparticles. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD) plays a crucial role in triggering the antitumor immune response in the tumor microenvironment (TME). Recently, considerable attention has been dedicated to ferroptosis, a type of ICD that is induced by intracellular iron and has been demonstrated to change the immune desert status of the TME. However, among cancers that are characterized by an immune desert, such as prostate cancer, strategies for inducing high levels of ferroptosis remain limited. Radiated tumor cell-derived microparticles (RMPs) are radiotherapy mimetics that have been shown to activate the cGAS-STING pathway, induce tumor cell ferroptosis, and inhibit M2 macrophage polarization. RMPs can also act as carriers of agents with biocompatibility. In the present study, we designed a therapeutic system wherein the ferroptosis inducer RSL-3 was loaded into RMPs, which were tested in in vitro and in vivo prostate carcinoma models established using RM-1 cells. The apoptosis inducer CT20 peptide (CT20p) was also added to the RMPs to aggravate ferroptosis. Our results showed that RSL-3- and CT20p-loaded RMPs (RC@RMPs) led to ferroptosis and apoptosis of RM-1 cells. Moreover, CT20p had a synergistic effect on ferroptosis by promoting reactive oxygen species (ROS) production, lipid hydroperoxide production, and mitochondrial instability. RC@RMPs elevated dendritic cell (DC) expression of MHCII, CD80, and CD86 and facilitated M1 macrophage polarization. In a subcutaneously transplanted RM-1 tumor model in mice, RC@RMPs inhibited tumor growth and prolonged survival time via DC activation, macrophage reprogramming, enhancement of CD8 + T cell infiltration, and proinflammatory cytokine production in the tumor. Moreover, combination treatment with anti-PD-1 improved RM-1 tumor inhibition. This study provides a strategy for the synergistic enhancement of ferroptosis for prostate cancer immunotherapies. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisProstatic NeoplasmsTumor MicroenvironmentCell-Derived MicroparticlesReactive Oxygen SpeciesMaleAnimalsMiceCell Line, TumorHumansMacrophagesApoptosisMice, Inbred C57BL

Stichwörter der Autor:innen

Cancer immunotherapyFerroptosisImmunogenic cell deathMacrophage reprogrammingMicroparticleTumor microenvironment

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Thoracic Surgery, ZhongNan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • College of Biomedicine and Health and College of Life Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China.
  • Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
  • Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. zengxiantao1128@whu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Deng, Z., Li, B., Yang, M., Lu, L., Shi, X., Lovell, J. F., Zeng, X., Hu, W., & Jin, H. (2024). Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02496-3

Vancouver

Deng Z, Li B, Yang M, Lu L, Shi X, Lovell JF, et al. Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis. Journal of Nanobiotechnology. 2024;22(1). doi:10.1186/s12951-024-02496-3

BibTeX
@article{Deng2024,
  author = {Deng, Zihan and Li, Binghui and Yang, Muyang and Lu, Lisen and Shi, Xiujuan and Lovell, Jonathan F and Zeng, Xiantao and Hu, Weidong and Jin, Honglin},
  title = {Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12951-024-02496-3}
}
Kostenlos starten →